Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ProBioGen, Tizona Therapeutics Enter Collaboration | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

ProBioGen, Tizona Therapeutics Enter Collaboration

To develop immune system centered treatments for cancer

By: Betsy Louda

, Contract Pharma

ProBioGen AG, a service & technology provider for complex therapeutic glycoproteins, has signed a second clinical immuno-oncology development and manufacturing agreement with Tizona Therapeutics, Inc., a privately held immunology company, to develop treatments for cancer.  

 

Under the terms of the agreement, ProBioGen is developing a stable cell line, followed by process development and GMP clinical manufacturing for Tizona’s lead antibody drug candidate.

 

“Tizona Therapeutics selected ProBioGen based on its excellent CHO.Right® development and manufacturing platform,” said Christine O’Brien, vice president of Program Management at Tizona Therapeutics. “ProBioGen’s collaborative approach, high standard for delivering quality product and timely execution of our project again make them an ideal partner for Tizona.”

 

Dr. Volker Sandig, ProBioGen’s chief scientific officer said, “ProBioGen’s and Tizona’s teams work together really well and ProBioGen is committed to delivering a quality product candidate within best-in-class development timelines to support potential clinical trials for Tizona Therapeutics.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics